(Q35796793)

10 August 2017

1 reference

title

Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease (English)

1 reference

10 August 2017

main subject

cardiovascular disease

1 reference

1 reference

Susan Zieman

1

1 reference

10 August 2017

David Kass

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

published in

Congestive Heart Failure

1 reference

10 August 2017

volume

10

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

144-9; quiz 150-1

1 reference

Protein glycation, diabetes, and aging

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Accelerated age-related browning of human collagen in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Molecular mechanisms of ageing in connective tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Advanced glycation: an important pathological event in diabetic and age related ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Aging of myocardial collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Pulse pressure--a review of mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Regulation of cardiovascular collagen synthesis by mechanical load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03223.X

10.1111/J.1527-5299.2004.03223.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference